We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Heparin Could Reduce Neurologic Deterioration Following Stroke

By HospiMedica International staff writers
Posted on 27 Aug 2012
Following an acute ischemic stroke, low-molecular weight heparin (LMWH) may help prevent early neurologic deterioration in patients with large artery occlusive disease (LAOD), according to a new study. More...


Researchers at the Prince of Wales Hospital (Hong Kong SAR, China) conducted a post-hoc analysis of a randomized, controlled, trial involving 353 patients following acute ischemic stroke and LAOD. The patients were randomly assigned to receive either subcutaneous LMWH (180 patients) or oral aspirin (173 patients) within 48 hours after stroke onset for 10 days; following intervention, all patients received aspirin once daily for six months. The main outcome measure was the prevention of early neurologic deterioration (END) within the first 10 days after index stroke.

The analysis showed that END occurred in 12 of the heparin group patients (6.7%) and 24 of the aspirin group patients (13.9%). The 7.2 percentage point difference yielded an odds ratio of 0.44 in favor of heparin. When the researchers looked at the individual components of their endpoint, they found that stroke progression within the first 10 days was 5% with heparin and 12.7% with aspirin, leading to an odds ratio of 0.36. The rates of early recurrent ischemic stroke (ERIS) and intracranial cerebral hemorrhage were not significantly different, as were the rates of other cerebral hemorrhages, both symptomatic and asymptomatic. The study was published in the August 13, 2012, issue of Archives of Neurology.

“For patients with acute ischemic stroke and LAOD, treatment with LMWH within 48 hours of stroke may reduce END during the first 10 days, mainly by preventing stroke progression,” concluded lead author Ka Sing Lawrence Wong, MD, and colleagues. “The similar rate of cerebral hemorrhage between LMWH and aspirin demonstrated that LMWH may be safely used in acute ischemic stroke.”

Patients with acute ischemic stroke and LAOD have an increased risk for early neurologic deterioration due to progressive stroke, ERIS, or symptomatic intracranial cerebral hemorrhage (SICH). LMWH has been widely advocated to prevent venous thromboembolism, but its risks and benefits in early ischemic stroke are inadequately defined.

Related Links:

Prince of Wales Hospital




Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Portable Jaundice Management Device
Nymphaea
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.